102 related articles for article (PubMed ID: 20887681)
21. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
22. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
23. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
24. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
25. Induced pluripotent stem (iPS) cell research overview.
Liu SP; Fu RH; Huang YC; Chen SY; Chien YJ; Hsu CY; Tsai CH; Shyu WC; Lin SZ
Cell Transplant; 2011; 20(1):15-9. PubMed ID: 20887681
[TBL] [Abstract][Full Text] [Related]
26. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
Cheng D; Lei L; Lu Z; Li Z; Wang H
Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
[TBL] [Abstract][Full Text] [Related]
27. Emerging methods for preparing iPS cells.
Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
[TBL] [Abstract][Full Text] [Related]
28. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
Heffernan C; Sumer H; Verma PJ
J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
[TBL] [Abstract][Full Text] [Related]
29. Mouse induced pluripotent stem cells.
Geoghegan E; Byrnes L
Int J Dev Biol; 2008; 52(8):1015-22. PubMed ID: 18956334
[TBL] [Abstract][Full Text] [Related]
30. Direct reprogramming 101.
Takahashi K
Dev Growth Differ; 2010 Apr; 52(3):319-33. PubMed ID: 20298260
[TBL] [Abstract][Full Text] [Related]
31. Induced pluripotent stem cells from swine (Sus scrofa): why they may prove to be important.
Roberts RM; Telugu BP; Ezashi T
Cell Cycle; 2009 Oct; 8(19):3078-81. PubMed ID: 19738434
[TBL] [Abstract][Full Text] [Related]
32. Prospects of induced pluripotent stem cell technology in regenerative medicine.
Zhang F; Citra F; Wang DA
Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
[TBL] [Abstract][Full Text] [Related]
33. [Blood cell generation from iPS cells].
Katayama N
Rinsho Ketsueki; 2014 Oct; 55(10):1795-802. PubMed ID: 25297742
[No Abstract] [Full Text] [Related]
34. iPS cells: a source of cardiac regeneration.
Yoshida Y; Yamanaka S
J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
[TBL] [Abstract][Full Text] [Related]
35. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
Menon S; Shailendra S; Renda A; Longaker M; Quarto N
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
